Skip to main content

Peer Review reports

From: Unfractionated heparin versus nafamostat mesylate for anticoagulation during continuous kidney replacement therapy: an observational study

Original Submission
19 Oct 2022 Submitted Original manuscript
24 Nov 2022 Reviewed Reviewer Report
2 Dec 2022 Reviewed Reviewer Report - Weerachai Chaijamorn
15 Dec 2022 Author responded Author comments - Tomoko Fujii
Resubmission - Version 2
15 Dec 2022 Submitted Manuscript version 2
20 Dec 2022 Author responded Author comments - Tomoko Fujii
Resubmission - Version 3
20 Dec 2022 Submitted Manuscript version 3
23 Dec 2022 Reviewed Reviewer Report - Weerachai Chaijamorn
23 Dec 2022 Reviewed Reviewer Report
30 Dec 2022 Author responded Author comments - Tomoko Fujii
Resubmission - Version 4
30 Dec 2022 Submitted Manuscript version 4
3 Jan 2023 Reviewed Reviewer Report
5 Jan 2023 Author responded Author comments - Tomoko Fujii
Resubmission - Version 5
5 Jan 2023 Submitted Manuscript version 5
Publishing
11 Jan 2023 Editorially accepted
16 Jan 2023 Article published 10.1186/s12882-023-03060-1

You can find further information about peer review here.

Back to article page